Leonurine alleviates lung ischemia–reperfusion injury through suppression of ferroptosis via RORα in male mice
Journal of Endocrinology · 2026
DOI: 10.1530/joe-25-0298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, 2026. Verfasst von Wanying Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Reperfusion Injury, Gallic Acid, Nuclear Receptor Subfamily 1, Group F, Member 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lung ischemia–reperfusion injury (LIRI) is a complex pathological condition that significantly impairs clinical outcomes following lung transplantation and thoracic surgery. Leonurine (LEO), an alkaloid derived from Leonurus japonicus, which has known anti-inflammatory and antioxidant properties, has shown therapeutic potential in various oxidative stress-related diseases. However, the effects of LEO on LIRI and its underlying mechanisms remain unclear. In the present study, a murine model of LIRI was established using wild-type mice. LEO treatment significantly improved lung histopathology, reduced oxidative stress, decreased pulmonary edema, and enhanced survival. Bioinformatics analyses – including volcano plot, KEGG enrichment, and GSEA – identified ferroptosis as a key regulatory pathway. In vivo and in vitro assays (HE, 4-HNE, and DHE labeling; immunofluorescence; and immunoblotting) confirmed that LEO inhibited ferroptosis in lung tissue and in MLE-12 cells. Mechanistically, LEO upregulated the RORα/Nrf2/GPX4 axis, thereby reducing lipid peroxidation and iron overload, as validated by BODIPY581/591 C11 and FeRhoNox-1 staining. Moreover, RORα inhibition abolished the anti-ferroptotic effects of LEO, indicating that its protective function is RORα dependent. Molecular docking further supported a potential direct interaction between LEO and RORα. Collectively, LEO alleviates LIRI by inhibiting ferroptosis through activation of the RORα/Nrf2/GPX4 signaling pathway. These findings suggest that LEO may serve as a promising therapeutic agent for the treatment of LIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.
- Zhejiang Province Engineering Research Center for Endoscope Instruments and Technology Development, Quzhou, China.
- Department of Pulmonary and Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
- Key Laboratory of Interventional Pulmonology of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Wanying Chen, Chengshui Chen, Shuai Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, W., Yang, L., Xue, Y., Zhang, Y., Chen, C., & Huang, S. (2026). Leonurine alleviates lung ischemia–reperfusion injury through suppression of ferroptosis via RORα in male mice. Journal of Endocrinology. https://doi.org/10.1530/joe-25-0298
Vancouver
Chen W, Yang L, Xue Y, Zhang Y, Chen C, Huang S. Leonurine alleviates lung ischemia–reperfusion injury through suppression of ferroptosis via RORα in male mice. Journal of Endocrinology. 2026. doi:10.1530/joe-25-0298
BibTeX
@article{Chen2026,
author = {Chen, Wanying and Yang, Li and Xue, Yincong and Zhang, Yuting and Chen, Chengshui and Huang, Shuai},
title = {Leonurine alleviates lung ischemia–reperfusion injury through suppression of ferroptosis via RORα in male mice},
journal = {Journal of Endocrinology},
year = {2026},
doi = {10.1530/joe-25-0298}
}
EUVIMED